Waldenstrom Macroglobulinemia clinical trials at UC Cancer
4 research studies open to eligible people
A Phase 1 Dose-Escalation and Cohort-Expansion of VLS-101 in Hematologic Malignancies
open to eligible people ages 18 years and up
A Phase 1 Dose-Escalation Study of VLS-101 in Hematological Malignancies
at UCLA UCSD
A Study of ARQ 531 in Patients With Selected Hematologic Malignancies
open to eligible people ages 18 years and up
This is an open-label, multi-center Phase 1/2 study of ARQ 531 in patients with selected hematologic malignancies.
at UCLA
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
open to eligible people ages 18 years and up
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 in patients with CLL/SLL and NHL who have failed or are intolerant to standard of care.
at UCSF
Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers
open to eligible people ages 18 years and up
This is an open-label Phase 1b/2 study in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)or non hodgkin's lymphoma (NHL) who have failed prior standard of care therapies including a BTK inhibitor where one is approved for the indication.
at UC Irvine UCSD
Last updated: